Clinical features and survival outcomes in patients with chronic myelomonocytic leukemia arising in the context of germline predisposition syndromes

Affiliations

¹ Mayo Clinic, Alix School of Medicine, Rochester, Minnesota, USA.
² Division of Hematology, Department of Internal Medicine, Mayo Clinic, Rochester, Minnesota, USA.
³ Department of Hematology, Northwestern Medicine, Chicago, Illinois, USA.
⁴ Section of Hematology-Oncology, Departments of Medicine and Human Genetics, The University of Chicago, Chicago, Illinois, USA.

Free article

Emma C St Martin et al. Am J Hematol. 2021.

Free article

. 2021 Sep 1;96(9):E327-E330.

doi: 10.1002/ajh.26250. Epub 2021 Jun 4.

¹ Mayo Clinic, Alix School of Medicine, Rochester, Minnesota, USA.
² Division of Hematology, Department of Internal Medicine, Mayo Clinic, Rochester, Minnesota, USA.
³ Department of Hematology, Northwestern Medicine, Chicago, Illinois, USA.
⁴ Section of Hematology-Oncology, Departments of Medicine and Human Genetics, The University of Chicago, Chicago, Illinois, USA.

No abstract available

References

1. Patnaik MM, Tefferi A. Chronic Myelomonocytic leukemia: 2020 update on diagnosis, risk stratification and management. Am J Hematol. 2020;95(1):97-115.
1. Mason CC, Khorashad JS, Tantravahi SK, et al. Age-related mutations and chronic myelomonocytic leukemia. Leukemia. 2016;30(4):906-913.
1. Patnaik MM, Itzykson R, Lasho TL, et al. ASXL1 and SETBP1 mutations and their prognostic contribution in chronic myelomonocytic leukemia: a two-center study of 466 patients. Leukemia. 2014;28(11):2206-2212.
1. Jaiswal S, Ebert BL. Clonal hematopoiesis in human aging and disease. Science. 2019;366(6465). https://doi.org/10.1126/science.aan4673.
1. Patnaik MM, Lasho TL. Genomics of myelodysplastic syndrome/myeloproliferative neoplasm overlap syndromes. Hematology Am Soc Hematol Educ Program. 2020;2020(1):450-459.